series-c-plus
Stage
3
Investors
About
Regulus Therapeutics is a biotechnology company focused on the discovery and development of innovative RNA-targeted drugs, primarily leveraging microRNA modulation to treat various diseases.
Explore Regulus Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.